Related references
Note: Only part of the references are listed.Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism
Gudrun Caspar-Bell et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Atherosclerosis and the Hypercholesterolemic AGE-RAGE Axis
Erick McNair et al.
INTERNATIONAL JOURNAL OF ANGIOLOGY (2016)
Low Levels of Serum Soluble Receptors for Advanced Glycation End Products, Biomarkers for Disease State: Myth or Reality
Kailash Prasad
INTERNATIONAL JOURNAL OF ANGIOLOGY (2014)
Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes
Keiko Fujisawa et al.
ATHEROSCLEROSIS (2013)
Ethnic and gender differences in advanced glycation end products measured by skin auto-fluorescence
Marjonneke J. Mook-Kanamori et al.
DERMATO-ENDOCRINOLOGY (2013)
Endogenous Secretory Receptor for Advanced Glycation End Products and Chronic Kidney Disease in the Elderly Population
Mansi Dalal et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes
Xystus H. L. Tam et al.
CLINICAL SCIENCE (2011)
Reduced soluble receptor for advanced glycation end-products in COPD
D. J. Smith et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes A 12-Year Follow-Up Study
Johanna W. M. Nin et al.
DIABETES (2010)
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease
Giuseppina Basta et al.
KIDNEY INTERNATIONAL (2010)
Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Francesca Santilli et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis Observations from the Dallas Heart Study
Jason B. Lindsey et al.
DIABETES CARE (2009)
Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study
J. W. M. Nin et al.
DIABETOLOGIA (2009)
Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients
Erick D. McNair et al.
INTERNATIONAL JOURNAL OF ANGIOLOGY (2009)
Decreased plasma soluble RAGE in patients with hypercholesterolemia:: Effects of statins
Francesca Santilli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Circulating glycotoxins and dietary advanced glycation endproducts: Two links to inflammatory response, oxidative stress, and aging
Jaime Uribarri et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2007)
Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects
Sho-ichi Yamagishi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients
K. Taki et al.
KIDNEY INTERNATIONAL (2006)
Soluble receptor for advanced glycation end products in patients with decreased renal function
M Kalousová et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis
H Koyama et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia
E Emanuele et al.
ARCHIVES OF NEUROLOGY (2005)
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
D Geroldi et al.
JOURNAL OF HYPERTENSION (2005)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes
M Challier et al.
CLINICAL CHEMISTRY (2005)
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
H Yonekura et al.
BIOCHEMICAL JOURNAL (2003)
Maillard reaction products in tissue proteins: New products and new perspectives
SR Thorpe et al.
AMINO ACIDS (2003)
The biology of the receptor for advanced glycation end products and its ligands
AM Schmidt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2000)
The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy
T Shimoike et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Advanced glycation end products: A nephrologist's perspective
DSC Raj et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Share Paper
